All USA USA Territories: American Samoa (USA); Guam (USA); Puerto Rico (USA); Virgin Islands (USA); Northern Mariana Islands (USA); USA Compact Free Associations:The Federated States of Micronesia (USA) Marshall Islands (USA) Republic of Palau (USA) International, Israel and Canada.
Grants to USA, Canada, and International nonprofit organizations, IHEs, and institutions for initiatives that enhance the quality of eye care. Funding is intended to support projects that include, but are not limited to, education and training, screening and assessment, rural care, technological installments and enhancements, construction and expansion of eye care centers, and raising awareness of eye diseases.
The eXcellence in Ophthalmology Vision Awards (XOVA) is an award program that aims to support initiatives that help deliver sustainable, improved eye care to reduce the burden of blindness around the world. Project outcomes should be specific, measurable, achievable, relevant and time-bound.
Others (see text field entitled "Additional Eligibility Criteria" for clarification)
Additional Eligibility Criteria
Applications must be made on behalf of an academic institution or organization* that endorses the application. An academic institution, such as a university, is one example of a suitable endorsing institution, but other types of organizations also qualify. (This is required because Novartis Pharma AG needs to execute a sponsorship agreement with the endorsing institution or organization prior to the release of any funding. It is not possible to fund, or execute an agreement with, an individual person.)
Patient advocacy groups, non-governmental organizations (NGOs), ophthalmologists, optometrists, specialist eye care nurses and allied eye healthcare professionals (including those in training) can all apply, provided the application is made on behalf of an academic institution or organization.
*An organization includes worldwide not-for-profit organizations**, hospitals and clinics. The organization does not have to be associated with an academic institution such as a university.
**Not-for-profit: XOVA actively encourages self-sustaining projects; however, the initiative should not set out to generate profits to be used for personal or corporate gain.
XOVA funding can be part of an ongoing long-term initiative, however the actual the actual project which the XOVA grant would fund must be in the planning phase and not yet started.
No project management support will be provided by Novartis Pharma AG.
XOVA is not intended to provide funding for research or clinical trials, nor for projects that have commenced prior to application submission.
Pre-Application Information
Deadline: 31 January 2022
This year’s XOVA winners will be announced during the EURETINA congress on 1-4 September 2022. Winning projects will also be highlighted on World Sight Day, held on Thursday 13th October 2022, and throughout the year on Novartis sponsored booths at international congresses.
If you are involved in more than one project that is eligible for the award, please complete an application form for each. Please do not apply for funding for the same project more than once.
If your application was not selected last year, you are encouraged to reapply.
We use cookies to enhance your browsing experience on GrantWatch.com. By continuing to use our site, you consent to the use of cookies. Learn more by exploring our comprehensive Cookie Policy
